Arbi-D 150/12.5mg Tablets – Irbesartan+Hydrochlorothiazide

Brand Name: Arbi-D

Generic Name: Irbesartan + Hydrochlorothiazide

Dosage Strength: 150mg Irbesartan + 12.5mg Hydrochlorothiazide

Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.

Packing: 10 Tablets

Description and Usage:

Arbi-D (Irbesartan+Hydrochlorothiazide) 150/12.5mg Tablets are indicated for the treatment of hypertension (high blood pressure) in adults. This combination medication helps to lower blood pressure through complementary mechanisms of action.

Irbesartan: Irbesartan is an angiotensin II receptor blocker (ARB) that works by blocking the binding of angiotensin II to its receptors, thereby causing vasodilation and lowering blood pressure.
Hydrochlorothiazide: Hydrochlorothiazide is a thiazide diuretic that works by increasing the excretion of sodium and water by the kidneys, leading to decreased blood volume and reduced vascular resistance, which lowers blood pressure.

Category: Hypertension and Heart Diseases

Description
Reviews (0)

Description

Arbi-D 150/12.5mg Tablets represent a potent combination of Irbesartan and Hydrochlorothiazide, aimed at combating hypertension.

This article explores its efficacy, usage, and implications.

Combating Hypertension:

Hypertension, or high blood pressure, is a pervasive health issue globally, linked to severe cardiovascular complications.

Arbi-D 150/12.5mg Tablets offer a strategic blend of Irbesartan and Hydrochlorothiazide to tackle this concern.

Understanding the Ingredients:

Irbesartan belongs to the class of angiotensin II receptor blockers, dilating blood vessels to lower blood pressure.

Hydrochlorothiazide acts as a diuretic, reducing fluid retention and subsequently blood pressure.

Efficacy and Usage:

Arbi-D 150/12.5mg Tablets are prescribed to manage hypertension in adults.

The recommended dosage typically involves one tablet daily, with adjustments as per the physician’s guidance.

Potential Side Effects:

Common side effects may include dizziness, fatigue, or electrolyte imbalances.

Patients should promptly report any unusual symptoms to their healthcare provider for further evaluation.

Precautions:

Patients with kidney or liver issues, pregnant or breastfeeding individuals, and those with electrolyte imbalances should exercise caution or avoid Arbi-D.

Regular monitoring is essential for optimal safety and efficacy.

Conclusion:

Arbi-D 150/12.5mg Tablets offer a valuable therapeutic option for hypertension management, leveraging the synergistic effects of Irbesartan and Hydrochlorothiazide. Adherence to prescribed dosages and monitoring for adverse effects are vital for ensuring patient safety and treatment success.

Buy: Arbi (Irbesartan) 150mg Tablets